| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RVL Pharmaceuticals plc | Chief Financial Officer | Ordinary Shares | 141K | $4.41K | $0.03 | 24 Jan 2022 | Direct |
| RVL Pharmaceuticals plc | Chief Financial Officer | Ordinary Shares | 22.9K | $713 | $0.03 | 24 Jan 2022 | By family limited liability company |
| Osmotica Pharmaceuticals plc | Chief Financial Officer | Share Option (Right to Buy) | 250K | 04 Nov 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CGTX | COGNITION THERAPEUTICS INC | 12 Aug 2022 | 0 | $0 | 3 | Interim CFO | 15 Aug 2022, 16:07 |
| RVLP | RVL Pharmaceuticals plc | 24 Jan 2022 | 1 | -$10.9K | 4 | Chief Financial Officer | 26 Jan 2022, 15:31 |
| RVLP | Osmotica Pharmaceuticals plc | 04 Nov 2021 | 1 | $0 | 4 | Chief Financial Officer | 08 Nov 2021, 15:06 |
| RVLP | Osmotica Pharmaceuticals plc | 18 May 2021 | 1 | -$20.2K | 4 | Chief Financial Officer | 20 May 2021, 16:06 |